Advertisement
Grab your lab coat. Let's get started
Welcome!
Welcome!
Create an account below to get 6 C&EN articles per month, receive newsletters and more - all free.
It seems this is your first time logging in online. Please enter the following information to continue.
As an ACS member you automatically get access to this site. All we need is few more details to create your reading experience.
Not you? Sign in with a different account.
Not you? Sign in with a different account.
ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Business
Arsenal Capital Sells Off Adhesives
by Marc S. Reisch
May 4, 2015
| A version of this story appeared in
Volume 93, Issue 18
Arsenal Capital Partners has agreed to sell Royal Adhesives & Sealants to another private equity firm, American Securities, for an undisclosed sum. Arsenal acquired Royal in 2010. After internal investment and eight acquisitions, the South Bend, Ind., firm now has annual adhesives and sealants sales in excess of $600 million. Arsenal has a long history of buying, building, and then selling chemical businesses. Among them are plasticizer maker Genovique Specialties, sold to Eastman Chemical in 2010, and battery electrolyte maker Novolyte Technologies, sold to BASF in 2012.
The power is now in your (nitrile gloved) hands
Sign up for a free account to get more articles. Or choose the ACS option that’s right for you.
Already have an ACS ID? Log in
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on X